Evolent Health (EVH) Other financing activities (2015 - 2020)

Evolent Health's Other financing activities history runs 6 years deep, the most recent figure standing at $33.7 million for Q1 2020.

• In Q1 2020, Other financing activities rose 5439.14% year-over-year to $33.7 million; the TTM figure through Mar 2020 stood at -$71.2 million (down 159.82% YoY), while the FY2019 annual figure was -$104.3 million, down 208.44% from the prior year.
• Other financing activities was $33.7 million for Q1 2020 at Evolent Health, up from -$104.9 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $120.1 million in Q3 2019 to a low of -$120.1 million in Q2 2019.
• Historically, Other financing activities has averaged $2.1 million across 5 years, with a median of $1.1 million in 2016.
• The sharpest annual moves came in 2019 and 2020: Other financing activities plunged 639.4% in 2019, then surged 5439.14% in 2020.
• A 5-year view of Other financing activities shows it stood at $1.6 million in 2016, then soared by 1240.5% to $21.4 million in 2017, then soared by 348.31% to $96.2 million in 2018, then plunged by 209.07% to -$104.9 million in 2019, then jumped by 132.11% to $33.7 million in 2020.
• The last three Other financing activities figures came in at $33.7 million (Q1 2020), -$104.9 million (Q4 2019), and $120.1 million (Q3 2019), per Business Quant data.